首页> 外文期刊>Bone marrow transplantation >Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome.
【24h】

Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome.

机译:Shwachman-Diamond综合征的成功同种异体造血干细胞移植(HSCT)。

获取原文
获取原文并翻译 | 示例
       

摘要

Shwachman-Diamond syndrome (SDS) is a rare genetic disorder characterized by pancreatic insufficiency, short stature, skeletal abnormalities and bone marrow dysfunction. Patients with SDS have varying degrees of marrow aplasia, which can be severe or progress to leukemic transformation. While allogeneic hematopoietic stem cell transplantation (HSCT) can be curative for the hematologic disturbances of SDS, a recent review of the literature reveals few survivors. Poor outcome with HSCT is often related to excessive cardiac and other organ toxicity from transplant preparative therapy. We describe two young children with SDS who developed aplastic anemia and subsequently underwent successful allografting using a non-cardiotoxic conditioning regimen. Case 1 received marrow from an HLA-identical sibling while case 2 received partially matched umbilical cord blood from an unrelated donor. Both patients are presently alive and well with sustained donor engraftment and excellent hematopoietic function at 36 and 22 months post-HSCT.
机译:Shwachman-Diamond综合征(SDS)是一种罕见的遗传性疾病,其特征是胰腺功能不全,身材矮小,骨骼异常和骨髓功能障碍。 SDS患者有不同程度的骨髓发育不全,可能严重或进展为白血病转化。虽然同种异体造血干细胞移植(HSCT)可以治愈SDS的血液系统疾病,但最近对文献的评论显示幸存者很少。 HSCT的预后不良通常与移植准备治疗引起的过度心脏和其他器官毒性有关。我们描述了两名患有再生障碍性贫血的SDS患儿,随后他们使用非心脏毒性条件疗法成功进行了同种异体移植。病例1从与HLA相同的兄弟姐妹那里接受了骨髓,而病例2从无关的捐献者那里得到了部分匹配的脐带血。目前,这两名患者均活着,并且在HSCT后36和22个月内持续供体移植并具有出色的造血功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号